What question did this study set out to answer?

The aim is to develop a unified framework for deriving and evaluating biomarker combinations to improve prediction of survival outcomes.

January 6, 2014PLoS ONEOpen Access

Boosting the Concordance Index for Survival Data – A Unified Framework To Derive and Evaluate Biomarker Combinations

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial evaluates biomarker combinations for survival outcomes in breast cancer, suggesting improved prediction accuracy.

The aim is to develop a unified framework for deriving and evaluating biomarker combinations to improve prediction of survival outcomes.
Proposed a gradient boosting algorithm for generating optimal linear biomarker combinations.
Focused on maximizing the smoothed concordance index for time-to-event data.
Evaluated performance through a large-scale simulation study and two molecular datasets.
Demonstrated higher discriminatory power than traditional methods for deriving gene signatures.
The new approach showed methodologically sound performance in predicting survival.
Specific improvement metrics provided showed significant enhancements over existing strategies.

Mayr et al. (2014) studied this question.

View Full Paper

Ask AI

Bookmark